Don't Jump to Extended-Duration VTE Prophylaxis in MEDICAL Patients

December 2019

A new rivaroxaban (Xarelto) indication will raise questions about inpatient and extended venous thromboembolism (VTE) prophylaxis.

You'll hear reps promote rivaroxaban 10 mg/day for VTE prophylaxis in MEDICAL inpatients...AND after discharge for up to 39 days total.

But point out the limitations with this new indication.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote